Company / Free Cash Flow per Share
Moleculin Biotech, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$176.65
FY2025
5-year range
-$176.65 / -$1.57
FY2021-FY2025
Trend
-1559.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -1559% YoY in FY2025, a notable deviation from the 8-year average annual change of -396%.
Based on SEC 10-K filings.
-176.65 in FY2025.
Declined from $-14.52 to $-176.65 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1559.2% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$176.65 | -1559.2% |
| FY2024 | -$10.65 | +26.7% |
| FY2023 | -$14.52 | - |
| FY2022 | - | - |
| FY2021 | -$1.57 | +30.5% |
| FY2020 | -$2.26 | -411.7% |
| FY2019 | -$0.44 | -29.2% |
| FY2018 | -$0.34 | -10.0% |
| FY2017 | -$0.31 | -389.5% |
| FY2016 | -$0.06 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026